Paperpal Prime Logo

Psychotherapy and Psychosomatics : Impact Factor & More

eISSN: 1423-0348pISSN: 0033-3190

Key Metrics

CiteScore
17
Eigenfactor
0.005 - 0.01
H-Index
110
Impact Factor
20 - 25
SJR
Q1Applied Psychology
SNIP
3.78
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Psychotherapy and Psychosomatics

Psychotherapy and Psychosomatics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KARGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1953
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Psychotherapy and Psychosomatics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Psychotherapy and Psychosomatics

Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways.
  • 29 Jun 2026
  • Psychotherapy and psychosomatics
Psychotherapy, Antidepressants, and Combined Treatment for Depression: A Network Meta-analysis on Social Functioning Outcomes.
  • 24 Jun 2026
  • Psychotherapy and psychosomatics
Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects.
  • 19 Jun 2026
  • Psychotherapy and psychosomatics
Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis.
  • 12 Jun 2026
  • Psychotherapy and psychosomatics
Clarifying Scope and Interpretation of Psychotherapeutic Consultation at Work: A Response to Recent Commentary.
  • 12 Jun 2026
  • Psychotherapy and psychosomatics
Does fatigue in patients with Post-COVID-19 Syndrome improve with rehabilitation?
  • 10 Jun 2026
  • Psychotherapy and psychosomatics
Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways.
  • 29 Jun 2026
  • Psychotherapy and psychosomatics
Psychotherapy, Antidepressants, and Combined Treatment for Depression: A Network Meta-analysis on Social Functioning Outcomes.
  • 24 Jun 2026
  • Psychotherapy and psychosomatics
Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects.
  • 19 Jun 2026
  • Psychotherapy and psychosomatics
Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis.
  • 12 Jun 2026
  • Psychotherapy and psychosomatics
Clarifying Scope and Interpretation of Psychotherapeutic Consultation at Work: A Response to Recent Commentary.
  • 12 Jun 2026
  • Psychotherapy and psychosomatics
Does fatigue in patients with Post-COVID-19 Syndrome improve with rehabilitation?
  • 10 Jun 2026
  • Psychotherapy and psychosomatics

FAQs on Psychotherapy and Psychosomatics